Back
Results - Announcements
Sales rise 50.52% to Rs 7.18 crore
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 1.81 crore in the March 2026 quarter
30-May-2026, 09:25
Net Loss of Pharmaids Pharmaceuticals reported to Rs 1.81 crore in the quarter ended March 2026 as against net loss of Rs 3.94 crore during the previous quarter ended March 2025. Sales rose 50.52% to Rs 7.18 crore in the quarter ended March 2026 as against Rs 4.77 crore during the previous quarter ended March 2025.
Net Loss of Pharmaids Pharmaceuticals reported to Rs 1.81 crore in the quarter ended March 2026 as against net loss of Rs 3.94 crore during the previous quarter ended March 2025. Sales rose 50.52% to Rs 7.18 crore in the quarter ended March 2026 as against Rs 4.77 crore during the previous quarter ended March 2025.
For the full year,net loss reported to Rs 11.72 crore in the year ended March 2026 as against net loss of Rs 10.78 crore during the previous year ended March 2025. Sales rose 43.34% to Rs 27.88 crore in the year ended March 2026 as against Rs 19.45 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 7.18 | 4.77 | 51 | 27.88 | 19.45 | 43 |
| OPM % | -4.74 | -81.76 | - | -48.53 | -65.55 | - |
| PBDT | -0.89 | -4.84 | 82 | -16.74 | -14.74 | -14 |
| PBT | -1.37 | -5.46 | 75 | -18.76 | -17.18 | -9 |
| NP | -1.81 | -3.94 | 54 | -11.72 | -10.78 | -9 |
Powered by Capital Market - Live News